Intercept Pharmaceuticals Inc

-

Company Reg D Offering

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Intercept Pharmaceuticals Inc
Firm
Fund #
CIK #0001270073
Sale2012-08-09 (50.0 M Offered, 30.0 M Sold)
Fund
Phone6467471000
Address18 Desbrosses Street
New York, New York 10013
Source [EDGAR]
Amount Raised ($M)
30241812602009201120132016
Company Details
Director
Custodian
Auditor
Marketer
Broker
Jurisdiction
Form D Offering
Filed2012-09-04 (D/A)
Exemption506
Remaining$20,000,000
DurationOne year or less
RevenueDecline to Disclose
DirectorsRole2011 - 2026
Klaus Veitinger Director
Jonathan Silverstein Director
David Shapiro Executive Officer
Barbara Duncan Executive Officer
Klaus Veltinger Director
Luciano Adorini Executive Officer
Lorenzo Tallarigo Director
Nicole Williams Director
Mark Pruzanski Executive Officer
Paolo Fundaro Director
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com